KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Equity Average (2016 - 2026)

Medtronic's Equity Average history spans 12 years, with the latest figure at $48.9 billion for Q1 2026.

  • For Q1 2026, Equity Average changed 0.5% year-over-year to $48.9 billion; the TTM value through Jan 2026 reached $48.9 billion, changed 0.5%, while the annual FY2024 figure was $51.0 billion, 2.21% down from the prior year.
  • Equity Average for Q1 2026 was $48.9 billion at Medtronic, up from $48.5 billion in the prior quarter.
  • Across five years, Equity Average topped out at $52.8 billion in Q3 2022 and bottomed at $48.4 billion in Q4 2024.
  • The 5-year median for Equity Average is $51.5 billion (2023), against an average of $50.7 billion.
  • The largest annual shift saw Equity Average increased 2.23% in 2022 before it fell 5.96% in 2024.
  • A 5-year view of Equity Average shows it stood at $52.4 billion in 2022, then dropped by 1.8% to $51.5 billion in 2023, then dropped by 5.96% to $48.4 billion in 2024, then grew by 0.12% to $48.5 billion in 2025, then increased by 0.88% to $48.9 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Equity Average are $48.9 billion (Q1 2026), $48.5 billion (Q4 2025), and $49.2 billion (Q1 2025).